Repligen acquired Refine Technology and its Alternating Tangential Flow system for continuous bioprocessing.

Provence Technologies? strengthens its expertise in therapeutic chemistry with acquisition of Synprosis.

Brunei harnesses its rich biodiversity and the growing halal market in a bid to develop its pharmaceutical sector.

Bend Research installs its first commercial-scale spray dryer at its Oregon facility.

Protecting intellectual property rights is vital to biopharmaceutical innovation.

The European Pharmacopoeia Commission re-evaluates its policy on the development of monographs for finished drug products.

DCAT's Sharp Sourcing 2014 educational program offers pharmaceutical and biopharmaceutical companies a forum to gain best practice insights in sourcing and procurement.

John Hopkins and UCSF-Stanford join FDA?s Centers of Excellence in Regulatory Science and Innovation.

FDA finalizes guidance on expedited programs for new drug approvals for treatment of serious and life-threatening conditions.

ASCO meeting attendees give artistic interpretations of cancer journeys in the form of public Hope Murals.

Bristol-Myers Squibb announced collaborations with CytomX on probodies and with Incyte in an immunotherapy clinical trial.

The 11th Annual Global Biomanufacturing Study includes a global analysis of 238 biomanufacturers and 178 suppliers in 31 countries.

The Bulk Pharmaceuticals Task Force asks FDA to respond to concerns about reduction in API facility compliance inspections.

Actavis develops a solid dosage manufacturing and packing facility at its Manati site in Puerto Rico.

EquipNet announced its 15th year of supplying asset management services.

DPx Holdings B.V. donated $110,000 to more than 20 different hospitals and organizations across the globe.

The EDQM grants Gnosis a CEP for teicoplanin, a true fermentation glycopeptide antibiotic produced by actinoplanes teichomyceticus strains.

Pfizer and the Avon Foundation for Women Breast Cancer Grants Program will award up to $1 million in grants to advocacy, academic, and other not-for-profit organizations.

The Philippines pharmaceutical market value is expected to increase from approximately $4.3 billion in 2013 to $8 billion by 2020.

Avantor Performance Materials appoints Michael Stubblefield as CEO.

GSK reports 5-year vaccine price freeze for countries graduating from GAVI Alliance.

FDA targets illegal online pharmacies that sell unapproved prescription drugs to US consumers.

GE Healthcare launches the Xuri IL-2 for the activation and expansion of T-lymphocytes.

Merck KGaA fill-finish expansion in Italy will be completed in 2017.

Cytovance Biologics and Selexys Pharmaceuticals enter an agreement for development of clinical trial materials.

PhRMA announces 119 new medicines are in development to treat mental and addictive disorders.

Brookfield continues to supply viscometers and rheometers for laboratory and on-line process control applications.

Pfizer will submit a NDA with FDA for palbociclib, a treatment for locally advanced or metastatic breast cancer.